Multidisciplinary consensus on the use of Cereton drug in treatment of central nervous system diseases with cognitive impairments of congenital and acquired origin in children. Resolution of the multidisciplinary panel of experts

N N Zavadenko,V P Zykov,D D Gaynetdinova,O V Agranovich,L S Chutko,G I Kovalev,S A Nemkova,S O Rogatkin,S A Chekalova,L D Panova,I V Sarvilina,Y E Nesterovsky,N V Ganina,O V Yurlova

doi:10.17116/jnevro2024124071145

Multidisciplinary consensus on the use of Cereton drug in treatment of central nervous system diseases with cognitive impairments of congenital and acquired origin in children. Resolution of the multidisciplinary panel of experts

N N Zavadenko, V P Zykov + Show 12 more

https://doi.org/10.17116/jnevro2024124071145

Copy DOI

Export

Save

Cite

Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Publication Date: Jan 1, 2024

#Origin In Children #Interdisciplinary Consensus #Multidisciplinary Consensus #Treatment Of Diseases #Use Of Drug #Multidisciplinary Panel Of Experts #All-Russian Forum #Interdisciplinary Council #Central Nervous System Diseases #Multidisciplinary Panel

Abstract
Full-Text
Similar Papers

Abstract

Listen

Interdisciplinary consensus on the use of Cereton in the treatment of central nervous system diseases with cognitive impairment of congenital and acquired genesis in children. Resolution of the interdisciplinary council of expertsXXIII All-Russian Forum "Zdravnitsa-2024".

Full Text

Published Version

Check institute access

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime

Multidisciplinary consensus on the use of Cereton drug in treatment of central nervous system diseases with cognitive impairments of congenital and acquired origin in children. Resolution of the multidisciplinary panel of experts